Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma

Dabrafenib and trametinib are two available molecules that have been approved for the treatment of metastatic melanoma with BRAF-V600E or V600K mutations. Their combined therapy has led to long-lasting survival benefits and substantially improved outcomes. Until now, only a few cases of severe hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Bumbacea, Roxana Silvia, Ali, Selda, Corcea, Sabina Loredana, Jinga, Dan Corneliu, Spiru, Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029543/
https://www.ncbi.nlm.nih.gov/pubmed/35454350
http://dx.doi.org/10.3390/medicina58040511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029543/
https://www.ncbi.nlm.nih.gov/pubmed/35454350
http://dx.doi.org/10.3390/medicina58040511

Ejemplares similares